Biofrontera (BFRIW) Research & Development (2023 - 2025)
Biofrontera (BFRIW) recorded quarterly Research & Development of $787000.0 in Q4 2025, down 7.85% quarter-over-quarter from $854000.0 in Q3 2025, and up 0.51% on a YoY basis from $783000.0 in Q4 2024.
Biofrontera (BFRIW) Research & Development (2023 - 2025) Analysis & Trends
Biofrontera's Research & Development history runs 3 years deep, the most recent figure standing at $787000.0 for Q4 2025.
- In Q4 2025, Research & Development rose 0.51% year-over-year to $787000.0; the TTM figure through Dec 2025 stood at $3.7 million (up 77.89% YoY), while the FY2025 annual figure was $3.7 million, up 78.03% from the prior year.
- Research & Development was $787000.0 for Q4 2025 at Biofrontera, down from $854000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.2 million in Q1 2025 to a low of $11000.0 in Q2 2023.
- Historically, Research & Development has averaged $535000.0 across 3 years, with a median of $669000.0 in 2024.
- Biggest YoY gain for Research & Development was 7000.0% in 2025; the steepest drop was 0.51% in 2025.
- A 3-year view of Research & Development shows it stood at $33000.0 in 2023, then soared by 2272.73% to $783000.0 in 2024, then gained by 0.51% to $787000.0 in 2025.
- The last three Research & Development figures came in at $787000.0 (Q4 2025), $854000.0 (Q3 2025), and $870000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 46.94 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 39.38 Mn |
| 10 | Biofrontera | - | - | 14.09 Mn | 787,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 787,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 669,000.00 |
| Jun 30, 2024 | 621,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 11,000.00 |